Abstract
To investigate the relationships among fecal isoflavone metabolism, dietary habit and Body Mass Index (BMI), 15 healthy men and 15 healthy women were recruited and provided stool samples for analysis of ex vivo anaerobic incubation of fecal suspension with daidzein. A negative correlation was observed between BMI and the dihydrodaidzein (DHD) production in men, and between BMI and the equol production in women. There was a positive correlation between intake of soluble dietary fiber and the DHD production in men. The results suggest that dietary habits and BMI are related to the metabolic activity of isoflavonoids by fecal intestinal microbiota.
Keywords: daidzein, dihydrodaidzein, equol, microbiota
Phytoestrogens are found in plants and have weak estrogenic activity. Much attention has focused on the health benefits of phytoestrogens. Daidzin, genistin, daidzein (the aglycone of daidzin), and genistein (the aglycone of genistin) are the most common isoflavones found in soy products. Human gastrointestinal bacteria play important roles in isoflavone metabolism [1, 2]. Equol is a metabolite of daidzein that is produced by intestinal microbiota [1]. The estrogenic activity of equol is stronger than that of daidzein [3]. Equol seems to be an important phytoestrogen produced by intestinal microbiota in the gut. However, individual variations in equol production have been identified. Only 30–50% of humans are equol producers [4, 5]. It has been reported that 59% of vegetarians and 25% of non-vegetarians are equol producers [6].
It has been suggested that equol-producing individuals may have superior cardiovascular health benefits [7], and people excreting equol may receive benefits from soya isoflavones in preventing cardiovascular disease [8]. In a case-control study involving residents in Japan and Korea, it was suggested that the ability to produce S-equol was closely related to a lower prevalence of prostate cancer [9]. S-equol administration to postmenopausal women reduced hot flash frequency [10]. S-equol production by microbiota seems to contribute positively to host health.
In a randomized, placebo-controlled crossover trial of 26 mildly hypercholesterolemic and/or hypertensive participants, soy-based milk and yoghurt improved plasma lipid levels only in the equol-positive group [11]. It has been reported that there are significant differences in the preventive effects of isoflavones on bone loss and fat accumulation observed between equol producers and non-producers in early postmenopausal women, with equol producers showing the greatest preventive effects [12].
Dihydrodaidzein (DHD) is a bacterial metabolite of the daidzein and is proposed as a precursor of equol [13]. Thus, DHD seem to be important bacterial metabolite. DPPH radical-scavenging activity of DHD has been reported. DHD has the ability to antagonize the contractile effects of noradrenaline and is a potential candidate for the cardioprotective therapeutics [14].
Intestinal microbiota appears to affect the efficacy of isoflavonoids in humans. However, few reports have focused on the relationships of isoflavonoids with gender differences, dietary habits, body mass index (BMI), and fecal isoflavone metabolism.
To investigate the role of microbiota in the metabolism of isoflavone, we measured daidzein metabolites produced by the anaerobic incubation of fecal suspension in healthy volunteers and investigated the relationship between these metabolites and several parameters determined by habitual dietary intakes.
Daidzein and equol were purchased from LC Laboratories (Woburn, MA, USA). DHD was purchased from Toronto Research Chemicals, Inc. (North York, Canada).
To estimate the nutritional factors affecting daidzein metabolism by intestinal microbiota we recruited 15 healthy men (mean age 33.6 ± 1.3; range 22–41) and 15 healthy women (mean age 33.9 ± 1.4; range 23–41) who did not have any gastrointestinal disease. Participants agreed to provide stool samples. Participants were asked about their habitual dietary intake in the week prior to stool samples being provided. The study is performed in accordance with the principles of the Declaration of Helsinki and with the approval of the Human Investigations Review Board of the National Food Research Institute, NARO and Kyoto Prefectural University of Medicine. Informed consent was obtained from all participants or their legal guardians.
A food frequency questionnaire based on food groups (FFQg) was answered by all participants and was used to calculate habitual dietary intake for the week prior to the stool sample collection. The FFQg was based on 29 food groups and 10 methods of cookery [15]. Energy and nutrition intake for the week was estimated for each participant from the data provided by the FFQg using FFQg software (Excel Eiyoukun, version 2.0, Yoshimura Y and Takahashi K, Kenpakusha, Tokyo, Japan). This software is based on the 5th revised and enlarged edition of the Standard Tables of Food Composition in Japan. Using the FFQg software, we obtained energy intake per day and measures of protein (g/d), fat (g/d), saturated fatty acid (g/d), monounsaturated fatty acid (g/d), polyunsaturated fatty acid (g/d), n-3 polyunsaturated fatty acid (g/d), n-6 polyunsaturated fatty acid (g/d), cholesterol (mg/d), carbohydrate (g/d), soluble dietary fiber (g/d), insoluble dietary fiber (g/d), total dietary fiber (g/d), retinol (μg/d), α-carotene (μg/d), β-carotene (μg/d), cryptoxanthin (μg/d), retinol equivalent (μg/d), vitamin D (μg/d), α-tocopherol (mg/d), vitamin K (μg/d), vitamin B1 (mg/d), vitamin B2 (mg/d), niacin (mg/d), vitamin B6 (mg/d), vitamin B12 (μg/d), folic acid (μg/d), pantothenic acid (mg/d), vitamin C (mg/d), K (mg/d), Na (mg/d), Ca (mg/d), Mg (mg/d), P (mg/d), Fe (mg/d), Zn (mg/d), Cu (mg/d), and Mn (mg/d).
We estimated the anaerobic equol and DHD production from the fecal microbiota ex vivo. After defecation, feces from participants were collected on paper sheets and quickly transferred into sterilized sampling containers for stool examination (Sarstedt K.K., Tokyo, Japan). Each sampling container was placed in an AnaeroPouch® with a CO2 generator (Mitsubishi Gas Chemical Company, Inc., Tokyo, Japan) and transported to the National Food Research Institute by parcel delivery service at a temperature kept below 10°C.
Approximately 0.1 g of feces was transferred to a sterilized glass homogenizer and 30-fold anaerobic medium was added and homogenized by gassing with O2-free CO2. Daidzein (5 mg) was dissolved in 1 ml dimethyl sulfoxide. The daidzein solution (1 µl) was transferred into 0.2 ml of homogenate. The solution was incubated under an atmosphere of CO2 generated using the AnaeroPack® system (Mitsubishi Gas Chemical Company, Inc., Tokyo, Japan) for 5 days at 37°C.
The anaerobic medium used was prepared as follows: brain heart infusion (37 g), agar (1 g), L-cysteine HCl·H2O (0.5 g) and Na2CO3 (4 g) were dissolved in 1,000 ml distilled water. Aliquots of the broth (9 ml) were placed in test tubes, gassed with O2-free CO2, sealed with a butyl rubber stopper and sterilized by autoclaving. After incubation, 0.3 ml distilled water was added to the reaction mixture, which was then treated with 500 µl of ethyl acetate, vortexed for 30 sec and centrifuged at 5,000 × g for 5 min at 4°C. The supernatant was transferred to an eggplant-type flask. The same volume of ethyl acetate as that used in the first extraction was added to the sediment, and the procedure was repeated. The supernatants from both extractions were pooled in an eggplant-type flask and evaporated completely using a rotary evaporator. The sample was then dissolved in 800 µl of 80% methanol and filtered through a 0.2 μm filter. The filtrates were used for LC-MS/MS analysis. LC-MS/MS analysis was performed using the same method as reported before [16].
Data are expressed as the mean ± standard error. All data were analyzed using Sigma Plot 11 (Systat Software, Inc., San Jose, CA, USA). When the data exhibited normally distributed populations with the same variances, the data were analyzed using the unpaired t-test. When the data did not exhibit normally distributed populations with the same variances, the data were analyzed using the Mann-Whitney rank sum test. To measure the strength of associations between pairs of the data, the data were analyzed using a Pearson product moment correlation test. A p-value of <0.05 was considered statistically significant.
The age range of the participants was 22–41 for men and 23–41 for women. The means and standard errors of the ages of the men and women were 33.6 ± 1.3 and 33.9 ± 1.4, respectively. The means and standard errors of the body weights of the men and women were 70.9 ± 2.3 and 50.6 ± 1.8, respectively. The means and standard errors of the BMI of the men and women were 23.2 ± 0.8 and 20.3 ± 0.7, respectively. There were significant differences in body weight (p<0.01) and height (p<0.01) between men and women. BMI was significantly greater in men than in women (p<0.01).
The results of the FFQg are shown in Table 1. For food intake, the amounts of calcium, vitamin K, folic acid, soluble dietary fiber, insoluble dietary fiber and total intake of dietary fiber were significantly greater in women than in men. The amounts of polyunsaturated fatty acids and omega-6 fatty acids were significantly greater in men than in women.
Table 1. Software data (FFQg ver. 2.0 Kenpaku-sha, Tokyo, Japan) calculations of dietary intake per day of 15 women and 15 men from data collected using the food frequency questionnaire based on food groups.
| Men (n=15) | Women (n=15) | p value | |
| Energy (Kcal/d) | 1,833.5 ± 93.8 | 1,631.8 ± 78.8 | 0.11 |
| Protein (g/d) | 57.7 ± 2.4 | 59.0 ± 2.7 | 0.73 |
| Fat (g/d) | 61.2 ± 4.3 | 56.0 ± 3.3 | 0.34 |
| Saturated fatty acid (g/d) | 18.4 ± 1.3 | 18.7 ± 1.3 | 0.85 |
| Monounsaturated fatty acid (g/d) | 22.8 ± 1.8 | 19.8 ± 1.1 | 0.16 |
| Polyunsaturated fatty acid (g/d) | 12.6 ± 0.9 | 10.2 ± 0.7 | 0.04 |
| n-3 Polyunsaturated fatty acid (g/d) | 2.1 ± 0.1 | 1.7 ± 0.2 | 0.05 |
| n-6 Polyunsaturated fatty acid (g/d) | 10.5 ± 0.8 | 8.4 ± 0.5 | 0.04 |
| Cholesterol (mg/d) | 261.7 ± 22.6 | 251.8 ± 19.3 | 0.90 |
| Carbohydrate (g/d) | 234.2 ± 12.7 | 211.5 ± 12.9 | 0.22 |
| Soluble dietary fiber (g/d) | 2.3 ± 0.2 | 3.0 ± 0.3 | 0.04 |
| Insoluble dietary fiber (g/d) | 6.8 ± 0.4 | 8.6 ± 0.6 | 0.02 |
| Total dietary fiber (g/d) | 9.4 ± 0.6 | 11.8 ± 0.8 | 0.03 |
| Retinol (μg/d) | 166.5 ± 11.9 | 188.2 ± 17.2 | 0.41 |
| α-Carotene (μg/d) | 407.0 ± 54.5 | 564.3 ± 81.9 | 0.09 |
| β-Carotene (μg/d) | 2,424.3 ± 312 | 3,387.2 ± 480.7 | 0.11 |
| Cryptoxanthin (μg/d) | 277.5 ± 60.3 | 456.0 ± 124.7 | 0.48 |
| Retinol equivalent (μg/d) | 401.5 ± 28.0 | 515.1 ± 46.7 | 0.08 |
| Vitamin D (μg/d) | 5.1 ± 0.4 | 5.3 ± 0.7 | 0.78 |
| α-Tocopherol (mg/d) | 5.8 ± 0.3 | 5.4 ± 0.3 | 0.28 |
| Vitamin K (μg/d) | 146.8 ± 8.7 | 188.6 ± 15.6 | 0.03 |
| Vitamin B1 (mg/d) | 0.8 ± 0.04 | 0.8 ± 0.04 | 0.34 |
| Vitamin B2 (mg/d) | 0.8 ± 0.04 | 1.0 ± 0.05 | 0.07 |
| Niacin (mg/d) | 13.8 ± 0.7 | 12.7 ± 0.7 | 0.29 |
| Vitamin B6 (mg/d) | 0.9 ± 0.05 | 1.0 ± 0.1 | 0.60 |
| Vitamin B12 (μg/d) | 5.3 ± 0.4 | 5.1 ± 0.6 | 0.78 |
| Folic acid (μg/d) | 190.4 ± 10.1 | 246.9 ± 18.5 | 0.02 |
| Pantothenic acid (mg/d) | 4.4 ± 0.2 | 4.8 ± 0.2 | 0.19 |
| Vitamin C | 54.4 ± 5.4 | 81.7 ± 10.4 | 0.08 |
| Na (mg/d) | 3,450.5 ± 277.4 | 2,868.8 ± 284.2 | 0.15 |
| K (mg/d) | 1,715.6 ± 90.9 | 1,989.1 ± 116.1 | 0.07 |
| Ca (mg/d) | 359.2 ± 31.4 | 493.9 ± 39.7 | 0.01 |
| Mg (mg/d) | 187.0 ± 9.9 | 201.4 ± 10.3 | 0.32 |
| P (mg/d) | 807.5 ± 36.7 | 877.3 ± 48.6 | 0.26 |
| Fe (mg/d) | 5.7 ± 0.2 | 6.2 ± 0.3 | 0.19 |
| Zn (mg/d) | 6.9 ± 0.3 | 7.1 ± 0.3 | 0.76 |
| Cu (mg/d) | 0.9 ± 0.04 | 0.9 ± 0.1 | 0.50 |
| Mn (mg/d) | 2.1 ± 0.1 | 2.1 ± 0.1 | 0.99 |
Analyses after ex vivo anaerobic incubation of fecal suspensions with daidzein in men and women revealed that the DHD concentrations was significantly greater in samples from men (39.3 ± 10.5 μmol/l) than in samples from women (10.6 ± 4.3 μmol/l) (p<0.05). Average equol concentrations tended to be higher in women (34.4 μmol/l) than in men (19.8 μmol/l), though there was no significant difference between the genders. There was no significant difference in daidzein concentrations between men (42.3 ± 8.8 μmol/l) and women (53.6 ± 12.8 μmol/l). It has been reported that soy isoflavone metabolism of microbiota is influenced by the food matrix, especially in women [17]. In the current study, there were differences in the food intake between women and men. These dietary differences might influence the production of different soy isoflavone metabolites by microbiota in men and women.
Analyses after ex vivo anaerobic incubation of fecal suspensions with daidzein in men and women revealed that there were some differences in the daidzein metabolism between men and women, so we analyzed the relationships of BMI, metabolites of daidzein, and data from the FFQg. The results suggested there are some gender differences in the correlation coefficients of between data from the FFQg items and DHD, and between those of the FFQg items and equol. The results also suggested there are some gender differences in the correlation coefficients of BMI and DHD, and of BMI and equol (Table 2, the correlation between results for the FFQg items and DHD production, and the correlation between results of the FFQg items and equol production; Table 3, the correlation result for BMI and results of the FFQg items, the correlation between BMI and the DHD production, and the correlation between BMI and the equol production).
Table 2. Correlation between results for the FFQg items and DHD production, and the correlation between results of the FFQg items and equol production.
| Equol (men) |
p value | Equol (women) |
p value | DHD (men) |
p value | DHD (women) |
p value | |
| Energy (Kcal/d) | 0.35 | 0.20 | –0.13 | 0.64 | 0.16 | 0.56 | –0.40 | 0.14 |
| Protein (g/d) | 0.53 | 0.04 | –0.17 | 0.56 | –0.02 | 0.94 | –0.05 | 0.85 |
| Fat (g/d) | 0.38 | 0.17 | –0.43 | 0.11 | 0.05 | 0.87 | –0.19 | 0.50 |
| Saturated fatty acid (g/d) | 0.36 | 0.19 | –0.46 | 0.08 | 0.11 | 0.71 | –0.06 | 0.83 |
| Monounsaturated fatty acid (g/d) | 0.37 | 0.18 | –0.42 | 0.12 | 0.02 | 0.93 | –0.27 | 0.33 |
| Polyunsaturated fatty acid (g/d) | 0.38 | 0.16 | –0.23 | 0.40 | 0.02 | 0.94 | –0.30 | 0.28 |
| n-3 Polyunsaturated fatty acid (g/d) | 0.39 | 0.15 | 0.01 | 0.98 | 0.02 | 0.94 | –0.28 | 0.32 |
| n-6 Polyunsaturated fatty acid (g/d) | 0.37 | 0.17 | –0.30 | 0.28 | 0.02 | 0.95 | –0.29 | 0.29 |
| Cholesterol (mg/d) | 0.21 | 0.46 | –0.50 | 0.06 | –0.33 | 0.22 | 0.15 | 0.61 |
| Carbohydrate (g/d) | 0.07 | 0.80 | 0.15 | 0.60 | 0.36 | 0.19 | –0.49 | 0.06 |
| Soluble dietary fiber (g/d) | 0.01 | 0.96 | 0.38 | 0.17 | 0.57 | 0.03 | –0.06 | 0.84 |
| Insoluble dietary fiber (g/d) | 0.19 | 0.51 | 0.37 | 0.18 | 0.42 | 0.12 | –0.04 | 0.89 |
| Total dietary fiber (g/d) | 0.12 | 0.66 | 0.36 | 0.19 | 0.49 | 0.06 | –0.06 | 0.84 |
| Retinol (μg/d) | 0.42 | 0.12 | –0.53 | 0.04 | –0.29 | 0.29 | 0.17 | 0.55 |
| α-Carotene (μg/d) | –0.13 | 0.65 | 0.24 | 0.40 | –0.09 | 0.74 | 0.24 | 0.39 |
| β-Carotene (μg/d) | –0.12 | 0.67 | 0.24 | 0.39 | –0.09 | 0.76 | 0.23 | 0.41 |
| Cryptoxanthin (μg/d) | 0.16 | 0.58 | 0.12 | 0.68 | –0.04 | 0.90 | –0.19 | 0.51 |
| Retinol equivalent (μg/d) | 0.06 | 0.82 | 0.04 | 0.90 | –0.22 | 0.43 | 0.26 | 0.35 |
| Vitamin D (μg/d) | 0.03 | 0.92 | 0.09 | 0.74 | 0.08 | 0.79 | –0.12 | 0.68 |
| α-Tocopherol (mg/d) | 0.19 | 0.51 | 0.12 | 0.68 | 0.12 | 0.66 | –0.26 | 0.35 |
| Vitamin K (μg/d) | 0.33 | 0.23 | 0.16 | 0.56 | –0.08 | 0.77 | 0.27 | 0.33 |
| Vitamin B1 (mg/d) | 0.49 | 0.06 | –0.08 | 0.77 | 0.07 | 0.81 | –0.04 | 0.88 |
| Vitamin B2 (mg/d) | 0.40 | 0.14 | –0.31 | 0.27 | –0.06 | 0.82 | 0.19 | 0.50 |
| Niacin (mg/d) | 0.50 | 0.06 | 0.07 | 0.79 | –0.03 | 0.92 | –0.14 | 0.63 |
| Vitamin B6 (mg/d) | 0.67 | 0.01 | 0.06 | 0.85 | –0.09 | 0.74 | 0.02 | 0.93 |
| Vitamin B12 (μg/d) | 0.24 | 0.38 | 0.06 | 0.83 | –0.11 | 0.69 | –0.09 | 0.76 |
| Folic acid (μg/d) | 0.33 | 0.23 | 0.25 | 0.36 | 0.10 | 0.71 | 0.19 | 0.50 |
| Pantothenic acid (mg/d) | 0.52 | 0.05 | –0.22 | 0.44 | 0.002 | 0.99 | 0.01 | 0.98 |
| Vitamin C | 0.24 | 0.39 | 0.27 | 0.32 | 0.07 | 0.82 | –0.01 | 0.97 |
| Na (mg/d) | 0.11 | 0.70 | 0.32 | 0.25 | 0.52 | 0.05 | –0.14 | 0.61 |
| K (mg/d) | 0.26 | 0.35 | 0.14 | 0.62 | 0.22 | 0.44 | 0.02 | 0.93 |
| Ca (mg/d) | 0.21 | 0.45 | –0.23 | 0.42 | 0.11 | 0.69 | 0.18 | 0.51 |
| Mg (mg/d) | 0.24 | 0.38 | 0.03 | 0.90 | 0.27 | 0.33 | –0.05 | 0.85 |
| P (mg/d) | 0.51 | 0.05 | –0.20 | 0.47 | 0.03 | 0.92 | 0.03 | 0.91 |
| Fe (mg/d) | 0.26 | 0.34 | –0.004 | 0.99 | 0.31 | 0.27 | 0.02 | 0.93 |
| Zn (mg/d) | 0.63 | 0.01 | –0.25 | 0.36 | –0.07 | 0.81 | –0.06 | 0.82 |
| Cu (mg/d) | 0.28 | 0.32 | 0.05 | 0.87 | 0.40 | 0.14 | –0.23 | 0.40 |
| Mn (mg/d) | 0.23 | 0.42 | 0.19 | 0.51 | 0.29 | 0.29 | –0.38 | 0.17 |
Table 3. Correlation result for BMI and results of the FFQg items, the correlation between BMI and the DHD production, and the correlation between BMI and the equol production.
| BMI (men) | p value | BMI (women) | p value | |
| Energy (Kcal/d) | 0.07 | 0.80 | –0.33 | 0.24 |
| Protein (g/d) | 0.28 | 0.31 | –0.22 | 0.42 |
| Fat (g/d) | 0.25 | 0.37 | –0.23 | 0.41 |
| Saturated fatty acid (g/d) | 0.20 | 0.48 | –0.09 | 0.75 |
| Monounsaturated fatty acid (g/d) | 0.32 | 0.25 | –0.22 | 0.44 |
| Polyunsaturated fatty acid (g/d) | 0.19 | 0.50 | –0.51 | 0.06 |
| n-3 Polyunsaturated fatty acid (g/d) | 0.11 | 0.70 | –0.65 | 0.01 |
| n-6 Polyunsaturated fatty acid (g/d) | 0.20 | 0.48 | –0.43 | 0.11 |
| Cholesterol (mg/d) | 0.44 | 0.10 | 0.20 | 0.48 |
| Carbohydrate (g/d) | –0.27 | 0.32 | –0.41 | 0.13 |
| Soluble dietary fiber (g/d) | –0.52 | 0.05 | –0.21 | 0.45 |
| Insoluble dietary fiber (g/d) | –0.43 | 0.11 | –0.37 | 0.18 |
| Total dietary fiber (g/d) | –0.47 | 0.08 | –0.33 | 0.24 |
| Retinol (μg/d) | 0.49 | 0.06 | 0.16 | 0.57 |
| α-Carotene (μg/d) | –0.06 | 0.82 | –0.08 | 0.77 |
| β-Carotene (μg/d) | –0.08 | 0.78 | –0.09 | 0.74 |
| Cryptoxanthin (μg/d) | –0.33 | 0.23 | –0.34 | 0.21 |
| Retinol equivalent (μg/d) | 0.10 | 0.73 | –0.06 | 0.82 |
| Vitamin D (μg/d) | –0.16 | 0.56 | –0.48 | 0.07 |
| α-Tocopherol (mg/d) | –0.07 | 0.79 | –0.68 | 0.01 |
| Vitamin K (μg/d) | 0.10 | 0.73 | –0.15 | 0.59 |
| Vitamin B1 (mg/d) | 0.28 | 0.32 | –0.13 | 0.64 |
| Vitamin B2 (mg/d) | 0.11 | 0.70 | –0.04 | 0.88 |
| Niacin (mg/d) | 0.32 | 0.25 | –0.29 | 0.30 |
| Vitamin B6 (mg/d) | 0.31 | 0.26 | –0.33 | 0.23 |
| Vitamin B12 (μg/d) | 0.09 | 0.75 | –0.42 | 0.12 |
| Folic acid (μg/d) | –0.18 | 0.53 | –0.18 | 0.51 |
| Pantothenic acid (mg/d) | 0.18 | 0.53 | –0.17 | 0.54 |
| Vitamin C | –0.30 | 0.28 | –0.34 | 0.22 |
| Na (mg/d) | –0.41 | 0.13 | –0.47 | 0.08 |
| K (mg/d) | –0.31 | 0.26 | –0.44 | 0.10 |
| Ca (mg/d) | –0.30 | 0.28 | –0.22 | 0.43 |
| Mg (mg/d) | –0.29 | 0.30 | –0.48 | 0.07 |
| P (mg/d) | 0.08 | 0.77 | –0.28 | 0.32 |
| Fe (mg/d) | –0.22 | 0.44 | –0.408 | 0.13 |
| Zn (mg/d) | 0.44 | 0.11 | –0.20 | 0.47 |
| Cu (mg/d) | –0.24 | 0.39 | –0.52 | 0.05 |
| Mn (mg/d) | –0.24 | 0.40 | –0.53 | 0.04 |
| DHD (μmol/l) | –0.66 | 0.007 | 0.31 | 0.26 |
| Equol (μmol/l) | 0.73 | 0.002 | –0.40 | 0.14 |
A negative correlation (r=−0.66) was observed between BMI and the DHD concentration of the fecal incubation solutions from men. In men in the current study, a moderate positive correlation (r=0.57) was observed between soluble dietary fiber intake and the DHD concentration of the fecal incubation solutions from men. It has been reported that bacterial numbers in fecal matter are affected by the intake of soluble dietary fiber [18]. Soluble dietary fiber seems to have an impact on the metabolic activity of human intestinal microbiota. These results suggest that some bacterial groups in the microbiota involved in the DHD production might affect BMI in men. This is a novel result, as there are few reports of a relationship between BMI and the DHD-producing activity of fecal microbiota.
A weak negative correlation (r=−0.40) was observed between BMI and the equol concentration of the fecal incubation solutions from women. It has been reported that overweight or obese individuals show a higher proportion of non-producers of equol than in the rate of non-producers in the general population [19]. In a 1 year isoflavone intervention study in early postmenopausal Japanese women, there were significant differences between the equol producers and non-producers in the isoflavone group in terms of fat accumulation [12]. In women, intestinal bacterium related to equol production might affect BMI. However, a positive correlation (r=0.73) was observed between BMI and the equol concentration of the fecal incubation solutions from men. Recently, sex-characteristic-microbiota correlations have been reported [20]. Our different results show sex differences in the relationship between the fecal metabolic activities of isoflavonoids and BMI which might be due to the sex-characteristic-microbiota between men and women.
Like the relationship of soluble dietary fiber with BMI, there was also a weak positive correlation between the amount of total dietary fiber intake and equol production in women (r=0.36). It has been reported that diet containing inulin significantly increased the cecal and colonic concentration of butyrate [21]. Resistant starch feeding increased the cecal concentration of butyric acid [22]. Human colonic butyrate-producing strains exhibited growth on a substrate including short-chain fructooligosaccharides [23]. However, a combination of dietary fructooligosaccharides and isoflavone conjugates increased equol production in ovariectomized mice [24]. Resistant starch promotes equol production [25]. It has been reported that butyric acid increases the conversion ratio of daidzein to equol in equol-producing bacterium [26]. Butyrate stimulated the equol production in a culture of mixed bacteria [27]. These indicate that some dietary fiber intake increases the butyrate production by intestinal microbiota. It is possible that some dietary fiber and oligosaccharides might promote the equol production by intestinal microbiota in women.
This is the first report to explore the relationship between the fecal DHD activity and BMI in men. A limitation of this study was that we could not identify what kinds of intestinal bacterium affect BMI and what diet components increase the equol production in the human gut. Further studies are needed to clarify these points.
Acknowledgments
This study was financially supported by the grants for project research (Development of fundamental technology for analysis and evaluation of functional agricultural products and functional foods) from the Ministry of Agriculture, Forestry and Fisheries of Japan.
REFERENCES
- 1.Bowey E, Adlercreutz H, Rowland I. 2003. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol 41: 631–636. [DOI] [PubMed] [Google Scholar]
- 2.Chang YC, Nair MG. 1995. Metabolism of daidzein and genistein by intestinal bacteria. J Nat Prod 58: 1892–1896. [DOI] [PubMed] [Google Scholar]
- 3.Sathyamoorthy N, Wang TT. 1997. Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer 33: 2384–2389. [DOI] [PubMed] [Google Scholar]
- 4.Cassidy A, Brown JE, Hawdon A, Faughnan MS, King LJ, Millward J, Zimmer-Nechemias L, Wolfe B, Setchell KD. 2006. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr 136: 45–51. [DOI] [PubMed] [Google Scholar]
- 5.Song KB, Atkinson C, Frankenfeld CL, Jokela T, Wähälä K, Thomas WK, Lampe JW. 2006. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr 136: 1347–1351. [DOI] [PubMed] [Google Scholar]
- 6.Setchell KD, Cole SJ. 2006. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 136: 2188–2193. [DOI] [PubMed] [Google Scholar]
- 7.Clerici C, Setchell KD, Battezzati PM, Pirro M, Giuliano V, Asciutti S, Castellani D, Nardi E, Sabatino G, Orlandi S, Baldoni M, Morelli O, Mannarino E, Morelli A. 2007. Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr 137: 2270–2278. [DOI] [PubMed] [Google Scholar]
- 8.Cai Y, Guo K, Chen C, Wang P, Zhang B, Zhou Q, Mei F, Su Y. 2012. Soya isoflavone consumption in relation to carotid intima-media thickness in Chinese equol excretors aged 40–65 years. Br J Nutr 108: 1698–1704. [DOI] [PubMed] [Google Scholar]
- 9.Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, Song JM, Pantuck AJ. 2004. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34: 86–89. [DOI] [PubMed] [Google Scholar]
- 10.Jenks BH, Iwashita S, Nakagawa Y, Ragland K, Lee J, Carson WH, Ueno T, Uchiyama S. 2012. A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency. J Womens Health (Larchmt) 21: 674–682. [DOI] [PubMed] [Google Scholar]
- 11.Meyer BJ, Larkin TA, Owen AJ, Astheimer LB, Tapsell LC, Howe PR. 2004. Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann Nutr Metab 48: 67–78. [DOI] [PubMed] [Google Scholar]
- 12.Wu J, Oka J, Ezaki J, Ohtomo T, Ueno T, Uchiyama S, Toda T, Uehara M, Ishimi Y. 2007. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause 14: 866–874. [DOI] [PubMed] [Google Scholar]
- 13.Setchell KD, Clerici C. 2010. Equol: history, chemistry, and formation. J Nutr 140: 1355S–1362S. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Chin-Dusting JP, Fisher LJ, Lewis TV, Piekarska A, Nestel PJ, Husband A. 2001. The vascular activity of some isoflavone metabolites: implications for a cardioprotective role. Br J Pharmacol 133: 595–605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Takahashi K, Yoshimura Y, Kaimoto T, Kunii D, Komatsu T, Yamamoto S. 2001. Validation of a food frequency questionnaire based on food groups for estimating individual nutrient intake. Jpn J Nutr 59: 221–232. [Google Scholar]
- 16.Tamura M, Hori S, Nakagawa H. 2014. Intestinal bacterium TM-30: an S-equol-producing bacterium isolated from human feces is involved in estrogen metabolism in vitro. Food Sci Technol Res 20: 309–316. [Google Scholar]
- 17.Ahn-Jarvis J, Clinton SK, Riedl KM, Vodovotz Y, Schwartz SJ. 2012. Impact of food matrix on isoflavone metabolism and cardiovascular biomarkers in adults with hypercholesterolemia. Food Funct 3: 1051–1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Simões CD, Maukonen J, Kaprio J, Rissanen A, Pietiläinen KH, Saarela M. 2013. Habitual dietary intake is associated with stool microbiota composition in monozygotic twins. J Nutr 143: 417–423. [DOI] [PubMed] [Google Scholar]
- 19.Usui T, Tochiya M, Sasaki Y, Muranaka K, Yamakage H, Himeno A, Shimatsu A, Inaguma A, Ueno T, Uchiyama S, Satoh-Asahara N. 2013. Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status. Clin Endocrinol (Oxf) 78: 365–372. [DOI] [PubMed] [Google Scholar]
- 20.Bolnick DI, Snowberg LK, Hirsch PE, Lauber CL, Org E, Parks B, Lusis AJ, Knight R, Caporaso JG, Svanbäck R. 2014. Individual diet has sex-dependent effects on vertebrate gut microbiota. Nat Commun 5: 4500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kleessen B, Hartmann L, Blaut M. 2001. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Br J Nutr 86: 291–300. [DOI] [PubMed] [Google Scholar]
- 22.Henningsson AM, Margareta E, Nyman GL, Björck IM. 2003. Influences of dietary adaptation and source of resistant starch on short-chain fatty acids in the hindgut of rats. Br J Nutr 89: 319–328. [DOI] [PubMed] [Google Scholar]
- 23.Scott KP, Martin JC, Duncan SH, Flint HJ. 2014. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol Ecol 87: 30–40. [DOI] [PubMed] [Google Scholar]
- 24.Ohta A, Uehara M, Sakai K, Takasaki M, Adlercreutz H, Morohashi T, Ishimi Y. 2002. A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice. J Nutr 132: 2048–2054. [DOI] [PubMed] [Google Scholar]
- 25.Tousen Y, Abe F, Ishida T, Uehara M, Ishimi Y. 2011. Resistant starch promotes equol production and inhibits tibial bone loss in ovariectomized mice treated with daidzein. Metabolism 60: 1425–1432. [DOI] [PubMed] [Google Scholar]
- 26.Minamida K, Tanaka M, Abe A, Sone T, Tomita F, Hara H, Asano K. 2006. Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine. J Biosci Bioeng 102: 247–250. [DOI] [PubMed] [Google Scholar]
- 27.Decroos K, Vanhemmens S, Cattoir S, Boon N, Verstraete W. 2005. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch Microbiol 183: 45–55. [DOI] [PubMed] [Google Scholar]